<--- Back to Details
First PageDocument Content
Oncology / Breast cancer / Oncogenes / Ribbon symbolism / HER2/neu / ErbB / Epidermal growth factor receptor / Risk factors for breast cancer / Cancer / Medicine / Biology / Tyrosine kinase receptors
Date: 2004-07-31 14:32:49
Oncology
Breast cancer
Oncogenes
Ribbon symbolism
HER2/neu
ErbB
Epidermal growth factor receptor
Risk factors for breast cancer
Cancer
Medicine
Biology
Tyrosine kinase receptors

Breast Cancer and Family History : A Multivariate Analysis of Levels of Tumor HER2 Protein and Family History of Cancer in Women Who Have Breast Cancer STEVEN LEHRER, M.D ., PATRICIA LEE, PAUL TARTTER, M .D ., BRENDA SHA

Add to Reading List

Source URL: stevenlehrer.com

Download Document from Source Website

File Size: 389,95 KB

Share Document on Facebook

Similar Documents

37 | P a g e  Association between age at presentation and pathological features of breast cancer and its effect on survival; a comparative study done in Sri Lanka

37 | P a g e Association between age at presentation and pathological features of breast cancer and its effect on survival; a comparative study done in Sri Lanka

DocID: 1rdIi - View Document

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

DocID: 1rdcC - View Document

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona

DocID: 1pnOU - View Document

CURRICULUM VITAE  1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

CURRICULUM VITAE 1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

DocID: 1pi0O - View Document

EDITORIAL STAFF  From the Editor Debu Tripathy, MD Editor-in-Chief

EDITORIAL STAFF From the Editor Debu Tripathy, MD Editor-in-Chief

DocID: 1oyvT - View Document